Bleeding Disorders

Bleeding disorders encompass inherited and acquired conditions characterized by impaired hemostasis and an increased tendency to bleed. These disorders may involve deficiencies or dysfunctions of clotting factors, blood vessels, or platelets. Clinical presentations range from mild mucocutaneous bleeding to severe, life-threatening hemorrhage. Diagnosis requires a detailed clinical history, coagulation testing, and specialized laboratory assays. Management strategies depend on the underlying disorder and bleeding severity and may include factor replacement therapy, antifibrinolytic agents, and supportive care. Advances in recombinant therapies and gene-based approaches have transformed treatment outcomes for inherited bleeding disorders. Research continues to improve diagnostic accuracy, develop longer-acting therapies, and enhance patient quality of life. Bleeding disorders remain a cornerstone topic in hematology due to their clinical complexity and lifelong management needs.